Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations. [electronic resource]
Producer: 20170815Description: 1140-1149 p. digitalISSN:- 2005-6648
- Adult
- Aged
- Aged, 80 and over
- Anemia -- blood
- Antineoplastic Agents -- therapeutic use
- Body Mass Index
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease-Free Survival
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride -- therapeutic use
- Female
- Gefitinib
- Genetic Predisposition to Disease
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Molecular Targeted Therapy
- Multivariate Analysis
- Mutation
- Nutrition Assessment
- Nutritional Status
- Phenotype
- Proportional Hazards Models
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Retrospective Studies
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.